The present invention provides pharmaceutical compositions, formulations and methods for treating Alport syndrome by administering recombinant human collagen IV protein to a patient in need.
申请公布号
AU2015292582(A1)
申请公布日期
2017.02.02
申请号
AU20150292582
申请日期
2015.07.23
申请人
Goldfinch Biopharma, Inc.
发明人
Hodges, Bradley Lowell;Barnes, Thomas Michael;Reilly, Philip Raymond;Kowtoniuk, Walter Eugene
